Legal status · United States
Is BPC-157 with KPV legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. BPC-157 with KPV is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
BPC-157 with KPV in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Research use only. Neither component is an approved drug or a permitted compounding ingredient. |
| FDA approval status | Not approved and never evaluated as a combination. BPC-157 alone was reviewed by FDA staff for the July 2026 Pharmacy Compounding Advisory Committee, which found no adequate human data. |
| Human studies cited | 0 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the BPC-157 with KPV profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing BPC-157 with KPV is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What BPC-157 with KPV is
Two peptides sold together for gut complaints, most commonly 10 mg of each in a 20 mg vial. The combination has never been studied. One half has five small human studies by routes nobody uses, the other half has no human data of any kind, and the vial is injected while the claim is about the gut.
This is the most coherent blend in the vendor catalogue on paper, which is why it is worth being careful about. BPC-157 came out of gastric juice research and its animal literature is largely gastrointestinal.
Mechanism: KPV blocks NF-kB and MAP kinase signalling in intestinal epithelial and immune cells, which is the mechanism behind its mouse colitis results. BPC-157 acts through angiogenic and cytoprotective pathways described on its own page and shows gastrointestinal protection in rodent models.
Regulatory history: Not approved and never evaluated as a combination. BPC-157 alone was reviewed by FDA staff for the July 2026 Pharmacy Compounding Advisory Committee, which found no adequate human data.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for BPC-157 with KPV at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
BPC-157 with KPV in other countries
Frequently asked questions
Is BPC-157 with KPV legal in the United States?
No. BPC-157 with KPV is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: Research use only. Neither component is an approved drug or a permitted compounding ingredient.
Can I buy BPC-157 with KPV in the United States?
No approved product exists to buy. In the United States BPC-157 with KPV is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Research use only. Neither component is an approved drug or a permitted compounding ingredient.
Is BPC-157 with KPV FDA approved?
No. FDA status: Not approved and never evaluated as a combination. BPC-157 alone was reviewed by FDA staff for the July 2026 Pharmacy Compounding Advisory Committee, which found no adequate human data.. Current US classification: "Not approved; research use only". On the evidence, no human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for BPC-157 with KPV live on its compound profile.
BPC-157 with KPV profileThis page is general information about the regulatory status of BPC-157 with KPV in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.